488 related articles for article (PubMed ID: 22393151)
1. Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.
Bai L; Constantinides MG; Thomas SY; Reboulet R; Meng F; Koentgen F; Teyton L; Savage PB; Bendelac A
J Immunol; 2012 Apr; 188(7):3053-61. PubMed ID: 22393151
[TBL] [Abstract][Full Text] [Related]
2. Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo.
Yue SC; Nowak M; Shaulov-Kask A; Wang R; Yue D; Balk SP; Exley MA
J Immunol; 2010 Jan; 184(1):268-76. PubMed ID: 19949077
[TBL] [Abstract][Full Text] [Related]
3. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
4. An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.
Ly D; Tohn R; Rubin B; Blumenfeld H; Besra GS; Veerapen N; Porcelli SA; Delovitch TL
Clin Exp Immunol; 2010 May; 160(2):185-98. PubMed ID: 20015094
[TBL] [Abstract][Full Text] [Related]
5. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
Birkholz AM; Girardi E; Wingender G; Khurana A; Wang J; Zhao M; Zahner S; Illarionov PA; Wen X; Li M; Yuan W; Porcelli SA; Besra GS; Zajonc DM; Kronenberg M
J Immunol; 2015 Aug; 195(3):924-33. PubMed ID: 26078271
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
[TBL] [Abstract][Full Text] [Related]
7. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
[TBL] [Abstract][Full Text] [Related]
8. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
[TBL] [Abstract][Full Text] [Related]
9. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
11. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
12. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs.
Tatituri RV; Watts GF; Bhowruth V; Barton N; Rothchild A; Hsu FF; Almeida CF; Cox LR; Eggeling L; Cardell S; Rossjohn J; Godfrey DI; Behar SM; Besra GS; Brenner MB; Brigl M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1827-32. PubMed ID: 23307809
[TBL] [Abstract][Full Text] [Related]
13. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
14. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro.
Zeng SG; Ghnewa YG; O'Reilly VP; Lyons VG; Atzberger A; Hogan AE; Exley MA; Doherty DG
J Immunol; 2013 Aug; 191(4):1666-76. PubMed ID: 23851681
[TBL] [Abstract][Full Text] [Related]
15. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.
Tyznik AJ; Farber E; Girardi E; Birkholz A; Li Y; Chitale S; So R; Arora P; Khurana A; Wang J; Porcelli SA; Zajonc DM; Kronenberg M; Howell AR
Chem Biol; 2011 Dec; 18(12):1620-30. PubMed ID: 22195564
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
[TBL] [Abstract][Full Text] [Related]
17. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH.
Velmourougane G; Raju R; Bricard G; Im JS; Besra GS; Porcelli SA; Howell AR
Bioorg Med Chem Lett; 2009 Jul; 19(13):3386-8. PubMed ID: 19481452
[TBL] [Abstract][Full Text] [Related]
19. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
[TBL] [Abstract][Full Text] [Related]
20. NKT and tolerance.
Diana J; Beaudoin L; Gautron AS; Lehuen A
Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
